Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from affirm)

American Journal of Cardiology

Volumn 110, Issue 12, 2012, Pages 1799-1802

  Sullivan, Renee M ^a,b   Zhang, Jingyang ^a,b   Zamba, Gideon ^a,b   Lip, Gregory Y H ^a,b   Olshansky, Brian ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEART RATE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; STROKE; WARFARIN;

EID: 84870296694     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.014     Document Type: Article

References (13)

1. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen, B. Andersen Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation The Copenhagen AFASAK study Lancet 1 1989 175 799
2. Stroke Prevention in Atrial Fibrillation Investigators Stroke prevention in atrial fibrillation study Final results Circulation 84 1991 527 539
3. The Boston Area Anticoagulation Trial for Atrial Fibrillation investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1990 1505 1511
4. S.J. Connolly, A. Laupacis, M. Gent, R.S. Roberts, J.A. Cairns, C. Joyner Canadian Atrial Fibrillation Anticoagulation (CAFA) study J Am Coll Cardiol 18 1991 349 355
5. M.D. Ezekowitz, S.L. Bridgers, K.E. James, N.H. Carliner, C.L. Colling, C.C. Gornick, H. Krause-Steinrauf, J.F. Kurtzke, S.M. Nazarian, M.J. Radford, F.R. Rickles, R. Shabetai, D. Deykin Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators N Engl J Med 327 1992 1406 1412
6. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke EAFT (European Atrial Fibrillation Trial) study group Lancet 342 1993 1255 1262
7. R.G. Hart, O. Benavente, R. McBride, L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
8. S.J. Connolly, J. Pogue, J. Eikelboom, G. Flaker, P. Commerford, M.G. Franzosi, J.S. Healey, S. Yusuf ACTIVE W Investigators Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range Circulation 118 2008 2029 2037
9. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist, S.D. Corley Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
10. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators Atrial Fibrillation Follow-up Investigation of Rhythm Management - the AFFIRM study design Am J Cardiol 79 1997 1198 1202
11. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, E. Briët A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
12. M. Avgil Tsadok, C.A. Jackevicius, E. Rahme, K.H. Humphries, H. Behlouli, L. Pilote Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation JAMA 307 2012 1952 1958
13. D.B. Matchar, A. Jacobson, R. Dolor, R. Edson, L. Uyeda, C.S. Phibbs, J.E. Vertrees, M.C. Shih, M. Holodniy, P. Lavori THINRS Executive Committee and Site Investigators Effect of home testing of international normalized ratio on clinical events N Engl J Med 363 2010 1608 1620